Philips Issues Correction for Trilogy Evo Ventilators Following FDA Class I Recall
The Food and Drug Administration identifies the software update and nebulizer restrictions as the most serious type of recall.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
